Baldwin Wealth Partners’s GoodRx Holdings GDRX Stock Holding History

Baldwin Wealth Partners’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-191	Closed	-$1.33K	–	541
2024 Q3	$1.33K	Hold	191	–	–	﹤0.01%	994
2024 Q2	$1.49K	Hold	191	–	–	﹤0.01%	689
2024 Q1	$1.36K	Hold	191	–	–	﹤0.01%	653
2023 Q4	$1.28K	Hold	191	–	–	﹤0.01%	678
2023 Q3	$1.07K	Hold	191	–	–	﹤0.01%	702
2023 Q2	$1.05K	Hold	191	–	–	﹤0.01%	715
2023 Q1	$1.19K	Hold	191	–	–	﹤0.01%	746
2022 Q4	$890	Buy	+191	New	+$941	﹤0.01%	746
2021 Q3	–	Sell	-1,000	Closed	-$36K	–	652
2021 Q2	$36K	Hold	1,000	–	–	﹤0.01%	394
2021 Q1	$39K	Buy	+1,000	New	+$45K	﹤0.01%	371

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RRCP

Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Baldwin Wealth Partners's GDRX Position: Q4 2024 in Review

Baldwin Wealth Partners sold out of GoodRx Holdings (GDRX) in Q4 2024, closing a stake of 191 shares — an estimated $1.33K sold.

Baldwin Wealth Partners first reported a position in GDRX in Q1 2021 and held it in 10 quarters. The position peaked at $39K in Q1 2021. 170 funds tracked by Wall St. Rank hold GDRX as of Q4 2024.

Baldwin Wealth Partners reported no remaining GoodRx Holdings position as of Q4 2024 after selling out during the quarter.
Baldwin Wealth Partners sold 191 GoodRx Holdings shares in Q4 2024, an estimated $1.33K.
Baldwin Wealth Partners first reported a position in GoodRx Holdings in Q1 2021 and held it in 10 quarters.
Baldwin Wealth Partners's GoodRx Holdings position peaked at $39K in Q1 2021.
170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2024.

Based on Baldwin Wealth Partners's 13F filing for Q4 2024, filed 22 Jan 2025.